Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 19816193)

1.

Engineered interleukin-2 antagonists for the inhibition of regulatory T cells.

Liu DV, Maier LM, Hafler DA, Wittrup KD.

J Immunother. 2009 Nov-Dec;32(9):887-94. doi: 10.1097/CJI.0b013e3181b528da. Erratum in: J Immunother. 2010 Sep;33(7):671.

2.

IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.

Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M.

Exp Hematol. 2008 Feb;36(2):181-92. Epub 2007 Nov 26.

PMID:
18023521
3.

Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.

Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Moraga I, Raeber ME, Bowman GR, Novick P, Pande VS, Fathman CG, Boyman O, Garcia KC.

Nature. 2012 Mar 25;484(7395):529-33. doi: 10.1038/nature10975.

4.

STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.

Passerini L, Allan SE, Battaglia M, Di Nunzio S, Alstad AN, Levings MK, Roncarolo MG, Bacchetta R.

Int Immunol. 2008 Mar;20(3):421-31. doi: 10.1093/intimm/dxn002. Epub 2008 Feb 12.

5.

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, Lechler RI, Lombardi G, Garden OA.

Int Immunol. 2007 Jun;19(6):785-99. Epub 2007 Jun 1.

6.

A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells.

Guo Z, Khattar M, Schroder PM, Miyahara Y, Wang G, He X, Chen W, Stepkowski SM.

J Immunol. 2013 Apr 1;190(7):3153-62. doi: 10.4049/jimmunol.1200751. Epub 2013 Feb 20.

7.

Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.

Forward NA, Conrad DM, Power Coombs MR, Doucette CD, Furlong SJ, Lin TJ, Hoskin DW.

Biochem Biophys Res Commun. 2011 Apr 22;407(4):801-6. doi: 10.1016/j.bbrc.2011.03.103. Epub 2011 Apr 2.

PMID:
21443863
8.

Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.

Garg G, Tyler JR, Yang JH, Cutler AJ, Downes K, Pekalski M, Bell GL, Nutland S, Peakman M, Todd JA, Wicker LS, Tree TI.

J Immunol. 2012 May 1;188(9):4644-53. doi: 10.4049/jimmunol.1100272. Epub 2012 Mar 28.

9.

Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.

Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.

J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.

10.

The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells.

Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA.

J Leukoc Biol. 2008 Oct;84(4):973-80. doi: 10.1189/jlb.1107778. Epub 2008 Jul 23.

11.

[The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes].

Mitiushova EV, Shatrova AN, Zenin VV, Aksenov ND, Marakhova II.

Tsitologiia. 2013;55(6):421-9. Russian.

PMID:
25509109
12.

Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.

Gong G, Shao L, Wang Y, Chen CY, Huang D, Yao S, Zhan X, Sicard H, Wang R, Chen ZW.

Blood. 2009 Jan 22;113(4):837-45. doi: 10.1182/blood-2008-06-162792. Epub 2008 Nov 3.

13.

Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.

Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B, Bommhardt UH.

J Immunol. 2009 Nov 15;183(10):6124-34. doi: 10.4049/jimmunol.0900246. Epub 2009 Oct 19.

14.

The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells.

Sewgobind VD, Quaedackers ME, van der Laan LJ, Kraaijeveld R, Korevaar SS, Chan G, Weimar W, Baan CC.

Am J Transplant. 2010 Aug;10(8):1785-95. doi: 10.1111/j.1600-6143.2010.03200.x. Epub 2010 Jul 12.

15.

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH.

Diabetes. 2010 Feb;59(2):407-15. doi: 10.2337/db09-0694. Epub 2009 Oct 29.

16.

Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.

Asanuma S, Tanaka J, Sugita J, Kosugi M, Shiratori S, Wakasa K, Shono Y, Shigematsu A, Kondo T, Kobayashi T, Asaka M, Imamura M.

Ann Hematol. 2011 Jun;90(6):617-24. doi: 10.1007/s00277-010-1121-z. Epub 2010 Nov 24.

PMID:
21107839
17.

Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.

Gowda A, Ramanunni A, Cheney C, Rozewski D, Kindsvogel W, Lehman A, Jarjoura D, Caligiuri M, Byrd JC, Muthusamy N.

MAbs. 2010 Jan-Feb;2(1):35-41. Epub 2010 Jan 8.

18.

[Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].

Wang ZH, Zhu JY, Li T, Leng XS.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):844-7. Chinese.

PMID:
18756991
19.

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.

Strauss L, Czystowska M, Szajnik M, Mandapathil M, Whiteside TL.

PLoS One. 2009 Jun 22;4(6):e5994. doi: 10.1371/journal.pone.0005994.

20.

Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.

Ahn JS, Krishnadas DK, Agrawal B.

Int Immunol. 2007 Mar;19(3):227-37. Epub 2007 Feb 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk